EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark QURE was filed as Word mark on 01/19/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application opposed".
| Trademark form | Word mark |
| File reference | 018976340 |
| Application date | January 19, 2024 |
| Publication date | April 18, 2024 |
Trademark owner
Paasheuvelweg 25
1105 BP Amsterdam
NL
1105 BP Amsterdam
NL
Trademark representatives
Rembrandt Tower, 28th Floor, Amstelplein 1
1096 HA Amsterdam
NL
Objection / Complaint
05/29/2024: Likelihood of confusion
Applicant
Medis Group, d.o.o.
goods and services
1
Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors for non-medical research purposes
5
Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy
42
Research, product development and consultancy in the field of biotechnology, biologics, pharmaceutics, medical science, chemistry and biochemistry; information and advice in the field of all the aforementioned services
44
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; information and advice in the field of all the aforementioned services
ID: 11018976340